Clinical Trials
All Clinical Trials - Page 4 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07630454Phase 4Not Yet Recruiting
Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF
Tirzepatide
- NCT07619989N/ARecruiting
Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Incretin Receptor Agonists
Tirzepatide
- NCT07676331Phase 2Not Yet Recruiting
Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial
Tirzepatide
- NCT07710430Phase 4Recruiting
A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious Puberty
Gonadorelin
- NCT07848828Phase 4Recruiting
Autonomic and Renal Contributions to Hypertension With ADT
Gonadorelin
- NCT07179991N/ARecruiting
DDAVP Effect by TEG6 in Cardiac Surgery
Desmopressin
- NCT07298915Phase 3Not Yet Recruiting
The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)
Tirzepatide
- NCT07668765N/ANot Yet Recruiting
GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity
Tirzepatide
- NCT07671391Phase 2Not Yet Recruiting
A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect of LAE102 Injection in Combination With Tirzepatide on Body in Obese Participants
Tirzepatide
- NCT07695454N/ARecruiting
Imaging in Semaglutide Study
Semaglutide
- NCT07455903Phase 2Recruiting
Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
Gonadorelin
- NCT07684144Phase 3Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Maridebart-Cafraglutide
- NCT07218354Phase 3Recruiting
Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)
Semaglutide
- NCT07588438Phase 4Recruiting
Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.
Tirzepatide
- NCT07573163Phase 2Recruiting
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion
Tirzepatide
- NCT07684235Phase 3Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Maridebart-Cafraglutide
- NCT07496463Phase 2Enrolling By Invitation
Setmelanotide to Treat Obesity in a Patient With Pseudohypoparathyroidism Type 1a (PHP1a)
Setmelanotide
- NCT07697391Phase 4Not Yet Recruiting
AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes
Tirzepatide
- NCT07728669N/ARecruiting
Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy
Semaglutide
- NCT07679516N/ANot Yet Recruiting
Postprandial Regulation of Bone Perfusion in Healthy Individuals
Pramlintide
- NCT07738276Phase 3Not Yet Recruiting
Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With Obesity
Tirzepatide
- NCT07732426N/ARecruiting
Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction Tendencies
Semaglutide
- NCT07613307Phase 3Recruiting
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
Orforglipron
- NCT07835360N/ARecruiting
Body Composition Changes After Initiation of GLP-1 Receptor Agonists in Adults With Obesity or Type 2 Diabetes
Tirzepatide
- NCT07668336Phase 3Recruiting
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Dulaglutide
- NCT06820281Phase 2Recruiting
Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes
Tirzepatide
- NCT07531251Phase 4Recruiting
Clinical Trial in Patients With Barth Syndrome- 4TAZPower
Elamipretide
- NCT07635953Phase 3Not Yet Recruiting
New Triple Combination Therapy in Newly Diagnosed Type 2 Diabetes
Tirzepatide
- NCT07636239N/ANot Yet Recruiting
Eating Behavior, Nutritional Status and Appetite Hormones After Bariatric Surgery
Ghrp-6
- NCT07403604Phase 1Recruiting
Effect of Insulin Lowering on Lipogenesis
Octreotide
- NCT07537686Phase 2Not Yet Recruiting
Glucagon-like Peptide 2 (GLP-2) in Undernourished Women Improving From Histology-Confirmed Environmental Enteric Dysfunction (EED)
Teduglutide
- NCT07700030N/ANot Yet Recruiting
High-protein plUs reSistance Training in gLucagon-like pEptide 1 Receptor Agonist Users (HUSTLE)
Tirzepatide
- NCT07720414N/ARecruiting
Effects of GLP-1 RAs on Human Lactation Outcomes
Tirzepatide
- NCT07706088Phase 4Not Yet Recruiting
Effect of Tirzepatide on Diabetic Peripheral Sensorimotor Neuropathy
Tirzepatide
- NCT07430059Phase 1Not Yet Recruiting
Safety, Tolerability and Pharmacokinetics of a Subcutaneous Semaglutide Implant
Semaglutide
- NCT07411378Phase 2Not Yet Recruiting
Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss.
Semaglutide
- NCT07457164Phase 2Not Yet Recruiting
A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer
Gonadorelin
- NCT07654062Phase 4Not Yet Recruiting
Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE)
Mazdutide
- NCT07866183N/ARecruiting
Trial of Innovative Fat-loss Focused Approaches in Patients With Class I Obesity: a Comparative Study
Tirzepatide
- NCT07707778Phase 4Enrolling By Invitation
Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV
Tirzepatide
- NCT07663318Phase 1Completed
A Phase 1 Study to Evaluate the Relative Bioavailability of Octreotide Acetate Tablets(T25) Compared to MYCAPSSA® and The Food Effect on Pharmacokinetics Of Octreotide Acetate Tablets(T25)
Octreotide
- NCT07801820Phase 2Recruiting
Phase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes Mellitus
Semaglutide
- NCT07357766Phase 3Withdrawn
A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight
Semaglutide
- NCT07668388Phase 2Recruiting
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Semaglutide
- NCT07587775Phase 2Enrolling By Invitation
The Effect of Osteoporotic Medications on Vertebral Bone Quality Score
Abaloparatide
- NCT07728383Phase 4Recruiting
A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity
Semaglutide
- NCT07382024N/ANot Yet Recruiting
Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation
Tirzepatide
- NCT07673900Phase 1Recruiting
Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants
Semaglutide
- NCT07702461N/ARecruiting
Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists
Tirzepatide
- NCT07046819Phase 2Recruiting
Tirzepatide in MetALD
Tirzepatide